Word: panalba
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...antibiotic with a sulfa: the FDA believes firmly that these fixed-dosage forms are likely to give a patient either too much or too little of one drug or the other. But many physicians have gone on prescribing them. The most noted example was Upjohn's Panalba (tetracycline with novobiocin), which is now off the market. Soon to follow, if FDA has its way: Squibb's Mysteclin-F (tetracycline with amphotericin B) and Roerig's Signemycin line (tetracycline with troleandeomycin...
...cases in which FDA has taken decisive action, it has run into strong opposition. The agency is trying to remove from the market 1) a combination of two antibiotics, tetracycline and novobiocin, marketed by the Upjohn Co. as Panalba, and 2) a combination of tetracycline with an antifungal agent, sold as Mysteclin-F (E. R. Squibb & Sons), Declostatin (Lederle Laboratories) and Tetrastatin (J. B. Roerig division of Chas. Pfizer & Co. Inc.). Upjohn has already taken its case to the courts, and the other firms may do so as well. Both drugs are widely prescribed items, ringing up tens of millions...
| 1 |